Gesynta Pharma

Gesynta Pharma is a privately-held pharmaceutical company developing novel oral treatments for patients with chronic inflammatory conditions.

The company is based in Stockholm and has a virtual set-up with a management team highly experienced in drug development. Gesynta Pharma is operating with a team of experts in the fields of mPGES-1 medical research, drug discovery, and drug- and business development. Gesynta Pharma leverages expertise in arachidonic acid research to explore the anti-inflammatory and vasoprotective effects of mPGES-1 inhibition, for example in cardiovascular diseases and cancer.